Drug Profile
Naltrexone implantable pellets - BioCorRx
Alternative Names: BICX 102; BICX-104Latest Information Update: 18 Aug 2023
Price :
$50
*
At a glance
- Originator BioCorRx
- Developer BioCorRx; National Institute of Drug Abuse
- Class Anti-inflammatories; Antineoplastics; Antivirals; Cyclopropanes; Drug withdrawal therapies; Ethers; Eye disorder therapies; Irritable bowel syndrome therapies; Ketones; Morphinans; Non-opioid analgesics; Small molecules
- Mechanism of Action Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Alcoholism; Opioid-related disorders
Most Recent Events
- 15 Aug 2023 BioCorRx submits expanded access program application to the US FDA for Opioid-related disorders
- 15 Aug 2023 BioCorRx plans an expanded access programme for Opioid-related disorders
- 14 Aug 2023 BioCorRx expects decision on the US FDA Fast Track designation application for Opiod-related disorders in USA in the next month